Skip to content

Staar Surgical STAA Operating Cash Flow

Operating Cash Flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.51B-39.8%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$230M+9.0%
IAR
Integra LifeSciencesIART
$9.8M+187%
ITG
Integer HoldingsITGR
$24.7M-21.0%
Glaukos logo
GlaukosGKOS
-$12.53M+32.4%
HRO
HarrowHROW
-$8.99M-146%

Other financials

Income statement

See full
Revenue$93.5M+120%
Gross profit$68.9M+146%
Operating income$8.0M+114%
Net income$5.2M+110%
EPS (diluted)$0.10+109%

Balance sheet

See full
Cash & equivalents$131.9M-23.8%
Total debt$37.3M+1.7%
Total equity$352.4M+0.7%
Total assets$451.1M-1.4%

Cash flow

See full
CapEx$443.0K-69.8%
Free cash flow-$22.1M-207%

Valuation

See full
Market cap$1.44B+47.4%
Enterprise value$1.35B+61.6%
P/S+1.5×

Profitability

See full
Gross margin76.9%+2.9pp
Operating margin-9.1%-3.5pp
Net margin-7.2%-3.0pp
FCF margin-19.6%+55.9pp

Returns & leverage

See full
Return on equity-6%-2.4pp
Debt / equity0.1×0.0×
Current ratio5.1×+0.3×

Where this comes from

Reported directly by Staar Surgical in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Staar Surgical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Staar Surgical's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Staar Surgical's operating cash flow?
Staar Surgical (STAA) reported operating cash flow of -$21.7M in Q1 2026.
How has Staar Surgical's operating cash flow changed year-over-year?
Staar Surgical's operating cash flow decreased by 278.4% year-over-year, from -$5.73M to -$21.7M.
What is the long-term trend for Staar Surgical's operating cash flow?
Over 3 years (2021 to 2025), Staar Surgical's operating cash flow has grown at a -5.7% compound annual growth rate (CAGR), from $43.96M to -$36.9M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.